Related Experiment Videos
Tumors and tumor-like lesions of the kidney
Current Problems in Cancer
|February 1, 1986
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Erratum: Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE [Phys. Rev. Lett. 126, 171801 (2021)].
Physical review letters·2024
Measurement of the 2νββ Decay Half-Life of ^{130}Te with CUORE.
Physical review letters·2021
Improved Limit on Neutrinoless Double-Beta Decay in ^{130} Te with CUORE.
Physical review letters·2020
First Results from CUORE: A Search for Lepton Number Violation via 0νββ Decay of ^{130}Te.
Physical review letters·2018
Diagnosis and management of endometriosis: a systematic review of international and national guidelines.
BJOG : an international journal of obstetrics and gynaecology·2017
Current molecular targeting in solid tumors: Progress and perspectives.
Current problems in cancer·2026
Unraveling lung cancer complexity: Spatial omics in tumor microenvironment characterization and precision medicine.
Current problems in cancer·2026
Predictors of change in cognitive function for patients with cancer treated with allogeneic hematopoietic cell transplant.
Current problems in cancer·2026
Spatial transcriptomics of primary and metastatic ALK-rearranged NSCLC reveals site-specific adaptations.
Current problems in cancer·2026
Integrating a Tumor Size-Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody-Drug Conjugates in Non-Small Cell Lung Cancer.
CPT: pharmacometrics & systems pharmacology·2026
The Future of all-Comers Trials in the Era of Precision Oncology.
Clinical pharmacology and therapeutics·2026
MyoD and Myogenin regulatory cascade is targeted by tumor signals to repress myogenesis in cancer cachexia.
The Biochemical journal·2026
Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).
Journal of Alzheimer's disease : JAD·2026
Conferone: Sources, Anticancer Mechanisms, and Potential in Overcoming Chemoresistance - A Comprehensive Review.
Current pharmaceutical design·2026